|
Re: ZEN-3694 mCRPC Trial Status
|
5
|
Zenith Epigenetics
|
Oct 26, 2017 12:13PM
|
|
Re: ZEN-3694 Single Agent Trial Status
|
6
|
Zenith Epigenetics
|
Sep 18, 2017 11:17PM
|
|
Re: ZEN-3694 Single Agent Trial Status
|
6
|
Zenith Epigenetics
|
Sep 21, 2017 03:57AM
|
|
Re: ZEN-3694 Single Agent Trial Status
|
5
|
Zenith Epigenetics
|
Sep 19, 2017 01:04PM
|
|
Re: ZEN-3694 Single Agent Trial Status
|
7
|
Zenith Epigenetics
|
Jan 16, 2018 12:22AM
|
|
Re: ZEN-3694 Single Agent Trial Status
|
6
|
Zenith Epigenetics
|
Jan 16, 2018 09:22AM
|
|
Re: ZEN-3694/Enzalutamid... vs. Enzalutamide alone?
|
3
|
Zenith Epigenetics
|
Apr 14, 2018 12:45AM
|
|
Re: ZEN-3694/Enzalutamid... vs. Enzalutamide alone?
|
3
|
Zenith Epigenetics
|
Apr 08, 2018 01:16PM
|
|
Re: ZEN-3694/Enzalutamid... vs. Enzalutamide alone?
|
2
|
Zenith Epigenetics
|
Apr 08, 2018 11:23PM
|
|
Re: Zenith
|
2
|
Resverlogix Corp.
|
Nov 04, 2019 10:43AM
|
|
Re: Zenith a Loser Too
|
3
|
Resverlogix Corp.
|
Jun 16, 2020 06:08PM
|
|
Re: Zenith a Loser Too
|
4
|
Resverlogix Corp.
|
Jun 17, 2020 04:38AM
|
|
Re: Zenith a Loser Too
|
2
|
Resverlogix Corp.
|
Jun 17, 2020 11:57AM
|
|
Re: Zenith Abstract at AACR 2017 Meeting April 1-5
|
3
|
Zenith Epigenetics
|
Apr 01, 2017 07:34PM
|
|
Re: Zenith Abstract at AACR 2017 Meeting April 1-5
|
5
|
Zenith Epigenetics
|
Mar 08, 2017 01:34AM
|
|
Re: Zenith Abstract at AACR 2017 Meeting April 1-5
|
1
|
Zenith Epigenetics
|
Apr 03, 2017 01:01PM
|
|
Re: Zenith Abstract at AACR 2017 Meeting April 1-5
|
1
|
Zenith Epigenetics
|
Apr 03, 2017 01:49PM
|
|
Re: Zenith AGM - Q&A
|
3
|
Zenith Epigenetics
|
Dec 19, 2017 04:21PM
|
|
Re: Zenith AGM thoughts
|
3
|
Zenith Epigenetics
|
Nov 28, 2017 06:38PM
|
|
Re: Zenith AGM webcast 9/12/2018
|
5
|
Zenith Epigenetics
|
Sep 12, 2018 07:29PM
|
